aluates Reports

$ 0.0

Automative

Global Cancer Early Detection Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-37F10785

Global Cancer Early Detection Market Research Report 2022

BUY CHAPTERS

Global Cancer Early Detection Market Research Report 2024

Code: QYRE-Auto-37F10785

Report

April 2024

Pages:81

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Exact Sciences

GRAIL

Genetron Health

New Horizon Health

Burning Rock

Berry Oncology

Oncognostic GmbH

Epigenomics

Abbott

Qiagen NV

Shanghai Kunyuan Biotechnology

iStat Biomedical

Cancer Early Detection Market Size

The global Cancer Early Detection market was valued at US$ 215 million in 2023 and is anticipated to reach US$ 367.8 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.

Cancer Early Detection Market

The 2 components of early detection of cancer are early diagnosis (or downstaging) and screening. Early diagnosis focuses on detecting symptomatic patients as early as possible, while screening consists of testing healthy individuals to identify those having cancers before any symptoms appear.

The market for cancer early detection is rapidly expanding, driven by continuous innovation and advancements in medical technology, leading to a gradual increase in market size. Sales are consistently on the rise, primarily catering to early screening and diagnosis of various cancers such as lung, breast, and colorectal cancer. Future development trends are poised to concentrate on more precise biomarker detection, efficient imaging diagnostic techniques, and intelligent medical assistive tools, aiming to enhance the accuracy and convenience of cancer early detection, ultimately reducing cancer incidence rates effectively and improving the chances of successful treatment.

This report aims to provide a comprehensive presentation of the global market for Cancer Early Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Early Detection.

Report Scope

The Cancer Early Detection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Early Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Early Detection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Early Detection Market Report

Report Metric	Details
Report Name	Cancer Early Detection Market
Accounted market size in 2023	US$ 215 million
Forecasted market size in 2030	US$ 367.8 million
CAGR	7.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Colorectal Cancer Liver Cancer Lung Cancer Other
Segment by Application	Hospital Medical Center Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic, Epigenomics, Abbott, Qiagen, iStat Biomedical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Early Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cancer Early Detection Market growing?

Ans: The Cancer Early Detection Market witnessing a CAGR of 7.3% during the forecast period 2024-2030.

What is the Cancer Early Detection Market size in 2030?

Ans: The Cancer Early Detection Market size in 2030 will be US$ 367.8 million.

Who are the main players in the Cancer Early Detection Market report?

Ans: The main players in the Cancer Early Detection Market are Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic, Epigenomics, Abbott, Qiagen, iStat Biomedical

What are the Application segmentation covered in the Cancer Early Detection Market report?

Ans: The Applications covered in the Cancer Early Detection Market report are Hospital, Medical Center, Other

What are the Type segmentation covered in the Cancer Early Detection Market report?

Ans: The Types covered in the Cancer Early Detection Market report are Colorectal Cancer, Liver Cancer, Lung Cancer, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Early Detection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Colorectal Cancer

1.2.3 Liver Cancer

1.2.4 Lung Cancer

1.2.5 Other

1.3 Market by Application

1.3.1 Global Cancer Early Detection Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Medical Center

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Early Detection Market Perspective (2019-2030)

2.2 Cancer Early Detection Growth Trends by Region

2.2.1 Global Cancer Early Detection Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cancer Early Detection Historic Market Size by Region (2019-2024)

2.2.3 Cancer Early Detection Forecasted Market Size by Region (2025-2030)

2.3 Cancer Early Detection Market Dynamics

2.3.1 Cancer Early Detection Industry Trends

2.3.2 Cancer Early Detection Market Drivers

2.3.3 Cancer Early Detection Market Challenges

2.3.4 Cancer Early Detection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Early Detection Players by Revenue

3.1.1 Global Top Cancer Early Detection Players by Revenue (2019-2024)

3.1.2 Global Cancer Early Detection Revenue Market Share by Players (2019-2024)

3.2 Global Cancer Early Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cancer Early Detection Revenue

3.4 Global Cancer Early Detection Market Concentration Ratio

3.4.1 Global Cancer Early Detection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Early Detection Revenue in 2023

3.5 Cancer Early Detection Key Players Head office and Area Served

3.6 Key Players Cancer Early Detection Product Solution and Service

3.7 Date of Enter into Cancer Early Detection Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Early Detection Breakdown Data by Type

4.1 Global Cancer Early Detection Historic Market Size by Type (2019-2024)

4.2 Global Cancer Early Detection Forecasted Market Size by Type (2025-2030)

5 Cancer Early Detection Breakdown Data by Application

5.1 Global Cancer Early Detection Historic Market Size by Application (2019-2024)

5.2 Global Cancer Early Detection Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cancer Early Detection Market Size (2019-2030)

6.2 North America Cancer Early Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cancer Early Detection Market Size by Country (2019-2024)

6.4 North America Cancer Early Detection Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Early Detection Market Size (2019-2030)

7.2 Europe Cancer Early Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cancer Early Detection Market Size by Country (2019-2024)

7.4 Europe Cancer Early Detection Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cancer Early Detection Market Size (2019-2030)

8.2 Asia-Pacific Cancer Early Detection Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cancer Early Detection Market Size by Region (2019-2024)

8.4 Asia-Pacific Cancer Early Detection Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cancer Early Detection Market Size (2019-2030)

9.2 Latin America Cancer Early Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cancer Early Detection Market Size by Country (2019-2024)

9.4 Latin America Cancer Early Detection Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Early Detection Market Size (2019-2030)

10.2 Middle East & Africa Cancer Early Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cancer Early Detection Market Size by Country (2019-2024)

10.4 Middle East & Africa Cancer Early Detection Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Exact Sciences

11.1.1 Exact Sciences Company Detail

11.1.2 Exact Sciences Business Overview

11.1.3 Exact Sciences Cancer Early Detection Introduction

11.1.4 Exact Sciences Revenue in Cancer Early Detection Business (2019-2024)

11.1.5 Exact Sciences Recent Development

11.2 Grail

11.2.1 Grail Company Detail

11.2.2 Grail Business Overview

11.2.3 Grail Cancer Early Detection Introduction

11.2.4 Grail Revenue in Cancer Early Detection Business (2019-2024)

11.2.5 Grail Recent Development

11.3 Genetron Health

11.3.1 Genetron Health Company Detail

11.3.2 Genetron Health Business Overview

11.3.3 Genetron Health Cancer Early Detection Introduction

11.3.4 Genetron Health Revenue in Cancer Early Detection Business (2019-2024)

11.3.5 Genetron Health Recent Development

11.4 New Horizon Health

11.4.1 New Horizon Health Company Detail

11.4.2 New Horizon Health Business Overview

11.4.3 New Horizon Health Cancer Early Detection Introduction

11.4.4 New Horizon Health Revenue in Cancer Early Detection Business (2019-2024)

11.4.5 New Horizon Health Recent Development

11.5 Burning Rock

11.5.1 Burning Rock Company Detail

11.5.2 Burning Rock Business Overview

11.5.3 Burning Rock Cancer Early Detection Introduction

11.5.4 Burning Rock Revenue in Cancer Early Detection Business (2019-2024)

11.5.5 Burning Rock Recent Development

11.6 Berry Oncology

11.6.1 Berry Oncology Company Detail

11.6.2 Berry Oncology Business Overview

11.6.3 Berry Oncology Cancer Early Detection Introduction

11.6.4 Berry Oncology Revenue in Cancer Early Detection Business (2019-2024)

11.6.5 Berry Oncology Recent Development

11.7 Shanghai Kunyuan Biotechnology

11.7.1 Shanghai Kunyuan Biotechnology Company Detail

11.7.2 Shanghai Kunyuan Biotechnology Business Overview

11.7.3 Shanghai Kunyuan Biotechnology Cancer Early Detection Introduction

11.7.4 Shanghai Kunyuan Biotechnology Revenue in Cancer Early Detection Business (2019-2024)

11.7.5 Shanghai Kunyuan Biotechnology Recent Development

11.8 Oncognostic

11.8.1 Oncognostic Company Detail

11.8.2 Oncognostic Business Overview

11.8.3 Oncognostic Cancer Early Detection Introduction

11.8.4 Oncognostic Revenue in Cancer Early Detection Business (2019-2024)

11.8.5 Oncognostic Recent Development

11.9 Epigenomics

11.9.1 Epigenomics Company Detail

11.9.2 Epigenomics Business Overview

11.9.3 Epigenomics Cancer Early Detection Introduction

11.9.4 Epigenomics Revenue in Cancer Early Detection Business (2019-2024)

11.9.5 Epigenomics Recent Development

11.10 Abbott

11.10.1 Abbott Company Detail

11.10.2 Abbott Business Overview

11.10.3 Abbott Cancer Early Detection Introduction

11.10.4 Abbott Revenue in Cancer Early Detection Business (2019-2024)

11.10.5 Abbott Recent Development

11.11 Qiagen

11.11.1 Qiagen Company Detail

11.11.2 Qiagen Business Overview

11.11.3 Qiagen Cancer Early Detection Introduction

11.11.4 Qiagen Revenue in Cancer Early Detection Business (2019-2024)

11.11.5 Qiagen Recent Development

11.12 iStat Biomedical

11.12.1 iStat Biomedical Company Detail

11.12.2 iStat Biomedical Business Overview

11.12.3 iStat Biomedical Cancer Early Detection Introduction

11.12.4 iStat Biomedical Revenue in Cancer Early Detection Business (2019-2024)

11.12.5 iStat Biomedical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Exact Sciences

GRAIL

Genetron Health

New Horizon Health

Burning Rock

Berry Oncology

Oncognostic GmbH

Epigenomics

Abbott

Qiagen NV

Shanghai Kunyuan Biotechnology

iStat Biomedical

List of Tables

Table 1. Global Cancer Early Detection Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Colorectal Cancer

Table 3. Key Players of Liver Cancer

Table 4. Key Players of Lung Cancer

Table 5. Key Players of Other

Table 6. Global Cancer Early Detection Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Cancer Early Detection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Cancer Early Detection Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Cancer Early Detection Market Share by Region (2019-2024)

Table 10. Global Cancer Early Detection Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Cancer Early Detection Market Share by Region (2025-2030)

Table 12. Cancer Early Detection Market Trends

Table 13. Cancer Early Detection Market Drivers

Table 14. Cancer Early Detection Market Challenges

Table 15. Cancer Early Detection Market Restraints

Table 16. Global Cancer Early Detection Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Cancer Early Detection Market Share by Players (2019-2024)

Table 18. Global Top Cancer Early Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Early Detection as of 2023)

Table 19. Ranking of Global Top Cancer Early Detection Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Cancer Early Detection Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Cancer Early Detection Product Solution and Service

Table 23. Date of Enter into Cancer Early Detection Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Cancer Early Detection Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Cancer Early Detection Revenue Market Share by Type (2019-2024)

Table 27. Global Cancer Early Detection Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Cancer Early Detection Revenue Market Share by Type (2025-2030)

Table 29. Global Cancer Early Detection Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Cancer Early Detection Revenue Market Share by Application (2019-2024)

Table 31. Global Cancer Early Detection Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Cancer Early Detection Revenue Market Share by Application (2025-2030)

Table 33. North America Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Cancer Early Detection Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Cancer Early Detection Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Cancer Early Detection Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Cancer Early Detection Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Cancer Early Detection Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Cancer Early Detection Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Cancer Early Detection Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Cancer Early Detection Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Cancer Early Detection Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Cancer Early Detection Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Cancer Early Detection Market Size by Country (2025-2030) & (US$ Million)

Table 48. Exact Sciences Company Detail

Table 49. Exact Sciences Business Overview

Table 50. Exact Sciences Cancer Early Detection Product

Table 51. Exact Sciences Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)

Table 52. Exact Sciences Recent Development

Table 53. Grail Company Detail

Table 54. Grail Business Overview

Table 55. Grail Cancer Early Detection Product

Table 56. Grail Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)

Table 57. Grail Recent Development

Table 58. Genetron Health Company Detail

Table 59. Genetron Health Business Overview

Table 60. Genetron Health Cancer Early Detection Product

Table 61. Genetron Health Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)

Table 62. Genetron Health Recent Development

Table 63. New Horizon Health Company Detail

Table 64. New Horizon Health Business Overview

Table 65. New Horizon Health Cancer Early Detection Product

Table 66. New Horizon Health Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)

Table 67. New Horizon Health Recent Development

Table 68. Burning Rock Company Detail

Table 69. Burning Rock Business Overview

Table 70. Burning Rock Cancer Early Detection Product

Table 71. Burning Rock Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)

Table 72. Burning Rock Recent Development

Table 73. Berry Oncology Company Detail

Table 74. Berry Oncology Business Overview

Table 75. Berry Oncology Cancer Early Detection Product

Table 76. Berry Oncology Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)

Table 77. Berry Oncology Recent Development

Table 78. Shanghai Kunyuan Biotechnology Company Detail

Table 79. Shanghai Kunyuan Biotechnology Business Overview

Table 80. Shanghai Kunyuan Biotechnology Cancer Early Detection Product

Table 81. Shanghai Kunyuan Biotechnology Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)

Table 82. Shanghai Kunyuan Biotechnology Recent Development

Table 83. Oncognostic Company Detail

Table 84. Oncognostic Business Overview

Table 85. Oncognostic Cancer Early Detection Product

Table 86. Oncognostic Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)

Table 87. Oncognostic Recent Development

Table 88. Epigenomics Company Detail

Table 89. Epigenomics Business Overview

Table 90. Epigenomics Cancer Early Detection Product

Table 91. Epigenomics Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)

Table 92. Epigenomics Recent Development

Table 93. Abbott Company Detail

Table 94. Abbott Business Overview

Table 95. Abbott Cancer Early Detection Product

Table 96. Abbott Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)

Table 97. Abbott Recent Development

Table 98. Qiagen Company Detail

Table 99. Qiagen Business Overview

Table 100. Qiagen Cancer Early Detection Product

Table 101. Qiagen Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)

Table 102. Qiagen Recent Development

Table 103. iStat Biomedical Company Detail

Table 104. iStat Biomedical Business Overview

Table 105. iStat Biomedical Cancer Early Detection Product

Table 106. iStat Biomedical Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)

Table 107. iStat Biomedical Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cancer Early Detection Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cancer Early Detection Market Share by Type: 2023 VS 2030

Figure 3. Colorectal Cancer Features

Figure 4. Liver Cancer Features

Figure 5. Lung Cancer Features

Figure 6. Other Features

Figure 7. Global Cancer Early Detection Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Cancer Early Detection Market Share by Application: 2023 VS 2030

Figure 9. Hospital Case Studies

Figure 10. Medical Center Case Studies

Figure 11. Other Case Studies

Figure 12. Cancer Early Detection Report Years Considered

Figure 13. Global Cancer Early Detection Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Cancer Early Detection Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Cancer Early Detection Market Share by Region: 2023 VS 2030

Figure 16. Global Cancer Early Detection Market Share by Players in 2023

Figure 17. Global Top Cancer Early Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Early Detection as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Cancer Early Detection Revenue in 2023

Figure 19. North America Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Cancer Early Detection Market Share by Country (2019-2030)

Figure 21. United States Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Cancer Early Detection Market Share by Country (2019-2030)

Figure 25. Germany Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Cancer Early Detection Market Share by Region (2019-2030)

Figure 33. China Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Cancer Early Detection Market Share by Country (2019-2030)

Figure 41. Mexico Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Cancer Early Detection Market Share by Country (2019-2030)

Figure 45. Turkey Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Exact Sciences Revenue Growth Rate in Cancer Early Detection Business (2019-2024)

Figure 48. Grail Revenue Growth Rate in Cancer Early Detection Business (2019-2024)

Figure 49. Genetron Health Revenue Growth Rate in Cancer Early Detection Business (2019-2024)

Figure 50. New Horizon Health Revenue Growth Rate in Cancer Early Detection Business (2019-2024)

Figure 51. Burning Rock Revenue Growth Rate in Cancer Early Detection Business (2019-2024)

Figure 52. Berry Oncology Revenue Growth Rate in Cancer Early Detection Business (2019-2024)

Figure 53. Shanghai Kunyuan Biotechnology Revenue Growth Rate in Cancer Early Detection Business (2019-2024)

Figure 54. Oncognostic Revenue Growth Rate in Cancer Early Detection Business (2019-2024)

Figure 55. Epigenomics Revenue Growth Rate in Cancer Early Detection Business (2019-2024)

Figure 56. Abbott Revenue Growth Rate in Cancer Early Detection Business (2019-2024)

Figure 57. Qiagen Revenue Growth Rate in Cancer Early Detection Business (2019-2024)

Figure 58. iStat Biomedical Revenue Growth Rate in Cancer Early Detection Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Oncology Imaging Equipment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1U15802

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global HER2 Tumor Marker Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-27D15553

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Targeted Radiotherapy Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2U15903

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Cell-Free Circulating Tumor DNA (ctDNA) Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2W15676

Tue Aug 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions